China Traditional Chinese Medicine Holdings Co (STU:WSG) EV-to-EBIT: -24.63 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:WSG China Traditional Chinese Medicine Holdings Co Ltd STU:WSG
78 GF Score
Price €0.22
GF Value €0.45
! 5 Warning Signs
View Full Analysis

What is China Traditional Chinese Medicine Holdings Co EV-to-EBIT?

China Traditional Chinese Medicine Holdings Co STU:WSG 78 EV-to-EBIT is -24.63 as of Aug. 01, 2026. GuruFocus rates STU:WSG with a GF Score™ of 78/100 and a GF Value™ of €0.45. The stock has 5 warning signs investors should review. Among 692 Drug Manufacturers companies, China Traditional Chinese Medicine Holdings Co ranks worse than 144508.53% on this metric.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, China Traditional Chinese Medicine Holdings Co's Enterprise Value is €791 Mil. China Traditional Chinese Medicine Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-32 Mil. Therefore, China Traditional Chinese Medicine Holdings Co's EV-to-EBIT for today is -24.63.

The historical rank and industry rank for China Traditional Chinese Medicine Holdings Co's EV-to-EBIT or its related term are showing as below:

STU:WSG' s EV-to-EBIT Range Over the Past 10 Years
Min: -37.69   Med: 11.55   Max: 36.42
Current: -24.18

During the past 13 years, the highest EV-to-EBIT of China Traditional Chinese Medicine Holdings Co was 36.42. The lowest was -37.69. And the median was 11.55.

STU:WSG's EV-to-EBIT is ranked worse than
100% of 692 companies
in the Drug Manufacturers industry
Industry Median: 15.77 vs STU:WSG: -24.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. China Traditional Chinese Medicine Holdings Co's Enterprise Value for the quarter that ended in Dec. 2025 was €1,098 Mil. China Traditional Chinese Medicine Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-32 Mil. China Traditional Chinese Medicine Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -2.92%.


China Traditional Chinese Medicine Holdings Co  (STU:WSG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

China Traditional Chinese Medicine Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2025 ) =EBIT / Enterprise Value (Q: Dec. 2025 )
=-32.108/1098.012618
=-2.92 %

China Traditional Chinese Medicine Holdings Co's Enterprise Value for the quarter that ended in Dec. 2025 was €1,098 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Traditional Chinese Medicine Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Traditional Chinese Medicine Holdings Co EV-to-EBIT Related Terms


China Traditional Chinese Medicine Holdings Co EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for China Traditional Chinese Medicine Holdings Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Traditional Chinese Medicine Holdings Co EV-to-EBIT Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.16 19.01 15.53 32.64 -35.97

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.53 0.00 32.64 0.00 -35.97

STU:WSG vs ZTS: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Traditional Chinese Medicine Holdings Co EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's EV-to-EBIT falls into.


STU:WSG
78GF Score
China Traditional Chinese Medicine Holdings Co Ltd STU:WSG
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Traditional Chinese Medicine Holdings Co EV-to-EBIT Calculation

China Traditional Chinese Medicine Holdings Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=790.730/-32.108
=-24.63

China Traditional Chinese Medicine Holdings Co's current Enterprise Value is €791 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Traditional Chinese Medicine Holdings Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -24.63 mean?
China Traditional Chinese Medicine Holdings Co (STU:WSG) has a EV-to-EBIT of -24.63 as of Aug. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. According to the industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #999999 out of 692 companies in the Drug Manufacturers industry.
Is China Traditional Chinese Medicine Holdings Co's EV-to-EBIT too high?
China Traditional Chinese Medicine Holdings Co's current EV-to-EBIT is -24.63. Based on the distribution chart, China Traditional Chinese Medicine Holdings Co ranks #999999 out of 692 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, China Traditional Chinese Medicine Holdings Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does China Traditional Chinese Medicine Holdings Co's EV-to-EBIT compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Traditional Chinese Medicine Holdings Co ranks #999999 out of 692 companies for EV-to-EBIT. This places China Traditional Chinese Medicine Holdings Co in the lower half of its industry. The industry median EV-to-EBIT is 15.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.77, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on China Traditional Chinese Medicine Holdings Co and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Traditional Chinese Medicine Holdings Co's current EV-to-EBIT is -24.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Traditional Chinese Medicine Holdings Co stock overvalued right now?
China Traditional Chinese Medicine Holdings Co (STU:WSG) has a current EV-to-EBIT of -24.63. The stock's GF Value™ is €0.45, compared to a current price of €0.22 — trading 51.1% below its estimated fair value. The current EV-to-EBIT is -24.63. China Traditional Chinese Medicine Holdings Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For China Traditional Chinese Medicine Holdings Co (STU:WSG), the current EV-to-EBIT is -24.63 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Traditional Chinese Medicine Holdings Co (STU:WSG) Overvalued in 2026?

Based on GuruFocus' analysis, China Traditional Chinese Medicine Holdings Co stock appears to be undervalued. The current stock price of €0.22 is trading 51.1% below its estimated GF Value™ of €0.45.

Key valuation signals for STU:WSG:

  • EV-to-EBIT: -24.63
  • GF Value™: €0.45 vs. price of €0.22 (51.1% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the STU:WSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Traditional Chinese Medicine Holdings Co Business Description

Other Exchanges CHIZF:USA00570:Hong Kong
Address 288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China, and also has its presence in Hong Kong and Other countries.
78GF Score

Get the complete analysis for STU:WSG

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price
€0.45
GF Value